scispace - formally typeset
W

Wupeng Liao

Researcher at University Health System

Publications -  27
Citations -  864

Wupeng Liao is an academic researcher from University Health System. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 11, co-authored 16 publications receiving 614 citations. Previous affiliations of Wupeng Liao include National University of Singapore.

Papers
More filters
Journal ArticleDOI

Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol

TL;DR: An update on vitamin E therapeutic potentials, protective effects and modes of action beyond cancer, with comparison of tocopherols against tocotrienols.
Journal ArticleDOI

Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases.

TL;DR: The renin–angiotensin system (RAS) has also been implicated in the regulation of inflammation, proliferation and fibrosis in pulmonary diseases such as asthma, acute lung injury, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).
Journal ArticleDOI

Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action.

TL;DR: Taken together, andrographolide and its analogs have great potential to be the next new class of anti‐inflammatory agents, and more androg grapholide molecules are likely moving towards clinical study stage in the near future.
Journal ArticleDOI

Glycogen Synthase Kinase-3β Inhibition Attenuates Asthma in Mice

TL;DR: In conclusion, inhibition of glycogen synthase kinase-3beta may provide a novel means for the treatment of allergic airway inflammation by significantly inhibited ovalbumin-induced increases in total cell counts, eosinophil counts, and IL-5, IL-13, and eotaxin levels recovered in bronchoalveolar lavage fluid in a dose-dependent manner.
Journal ArticleDOI

Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases

TL;DR: This review will compile the current findings of oligonucleotide therapeutic targets, verified in various respiratory disease models and in clinical trials, and evaluate different chemical modification approaches to improve the stability and potency of olig onucleotides for the treatment of respiratory diseases.